|
1CM9
CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
Deposited 1999-05-19
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
21–94(74 aa)
Chain B
21–94(74 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;pH 5.6
|
Resolution 2.10 Å
R-free 0.275
|
|
1HFF
NMR solution structures of the vMIP-II 1-10 peptide from Kaposi's sarcoma-associated herpesvirus.
Deposited 2000-12-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
24–33(10 aa)
Fragment:RESIDUES 1-10
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5;281 K;Ionic strength (raw mmCIF value) 20MM SODIUM ACETATE;Pressure 1
NMR sample composition
20MM SODIUM ACETATE, 1-2MM PEPTIDE, 1MM SODIUM AZIDE, 1MM DSS
|
Resolution not provided
|
|
1HFG
NMR solution structure of vMIP-II 1-71 from Kaposi's sarcoma-associated herpesvirus (minimized average structure).
Deposited 2000-12-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
24–94(71 aa)
Fragment:RESIDUES 1-71
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5;303 K;Pressure 1
|
Resolution not provided
|
|
1HFN
NMR solution structures of vMIP-II 1-71 from Kaposi's sarcoma-associated herpesvirus.
Deposited 2000-12-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
24–94(71 aa)
Fragment:RESIDUES 1-71
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5;303 K;Pressure 1
NMR sample composition
1MM DSS, 1MM NAN3, 20MM SODIUM ACETATE
|
Resolution not provided
|
|
1HHV
SOLUTION STRUCTURE OF VIRUS CHEMOKINE VMIP-II
Deposited 1998-12-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
21–94(74 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 3.25;308 K;Ionic strength (raw mmCIF value) 50 mM
NMR sample composition
90% H2O/10% D2O
|
Resolution not provided
|
|
1VMP
STRUCTURE OF THE ANTI-HIV CHEMOKINE VMIP-II
Deposited 1999-03-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
24–94(71 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.4;298 K;Ionic strength (raw mmCIF value) 0.01;Pressure 1
|
Resolution not provided
|
|
2FHT
Crystal Structure of Viral Macrophage Inflammatory Protein-II
Deposited 2005-12-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
24–94(71 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;298 K;0.1 M sodium citrate, 11% (w/v) PEG 4000, 11%(w/v) 2-propanol, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.70 Å
R-free 0.331
|
|
4RWS
Crystal structure of CXCR4 and viral chemokine antagonist vMIP-II complex (PSI Community Target)
Deposited 2014-12-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
24–94(71 aa)
|
Mutation:W5C
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5.5;293 K;100 mM sodium citrate pH 5.5, 28% PEG 400, 120 mM ammonium phosphate dibasic, 2-6% polypropylene P400, Lipidic cubic phase, temperature 293K
|
Resolution 3.10 Å
R-free 0.274
|